Login
$AZTA
$47.22 +$1.57 (3.44%) Live

Insider Transactions

What Azenta, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 2
Sells 0 0
Total trades 14 29

Shares traded

3 months 12 months
Acquired 0 5,663
Disposed 0 0
Net activity +0 +5,663

Common stock only — 28 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Pirogova Olga SVP and CHRO Nov 16 Withheld — tax / exercise cost · F −5,009 $43.86 −$220K 63,895
Pirogova Olga SVP and CHRO Nov 16 Withheld — tax / exercise cost · F −2,072 $43.86 −$90.9K 68,904
Pirogova Olga SVP and CHRO Nov 16 Grant / award · A +13,412 — — 70,976
Lin Lawrence Y. EVP, CFO and Treasurer Nov 16 Withheld — tax / exercise cost · F −4,413 $43.86 −$194K 129,048
Pirogova Olga SVP and CHRO Nov 12 Grant / award · A +10,339 — — 57,564
Lin Lawrence Y. EVP, CFO and Treasurer Nov 12 Grant / award · A +23,262 — — 133,461
Madaus Martin D Interim CEO Oct 22 Withheld — tax / exercise cost · F −1,294 $36.01 −$46.6K 41,308
Madaus Martin D Interim CEO Sep 22 Withheld — tax / exercise cost · F −1,456 $34.28 −$49.9K 42,602
Bello Erik J. VP Chief Accounting Officer Sep 15 Grant / award · A +4,586 — — 4,586
Pirogova Olga SVP and CHRO Sep 14 Grant / award · A +15,272 — — 47,225
Madaus Martin D Interim CEO Sep 14 Grant / award · A +36,653 — — 44,058
Lin Lawrence Y. EVP, CFO and Treasurer Sep 14 Grant / award · A +30,544 — — 110,199
Martin William E. Iii President Multiomics Sep 14 Grant / award · A +15,272 — — 33,062
Starr Ephraim SVP, Gen Counsel & Secretary Sep 14 Grant / award · A +15,272 — — 84,000
Pirogova Olga SVP and CHRO Aug 09 Withheld — tax / exercise cost · F −1,085 $32.04 −$34.8K 31,953
Starr Ephraim SVP, Gen Counsel & Secretary Jul 31 Open-market buy · P +335 $24.17 +$8.1K 68,728
Cornog William L Director May 18 Open-market buy · P +10,000 $16.38 +$164K 19,703
Starr Ephraim SVP, Gen Counsel & Secretary May 15 Withheld — tax / exercise cost · F −3,621 $16.02 −$58K 68,393
Martin William E. Iii President Multiomics Apr 28 Grant / award · A +17,790 $24.24 +$431K 17,790
Nova Tina Susan Director Feb 06 Grant / award · A +5,663 $27.85 +$158K 15,772

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support